|
|||||
|
|
Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: a critical assessment based on recently reported phase III trials in colorectal and breast cancer. |
|
| Authors: | Angelo Di Leo Harry Bleiberg Marc Buyse |
| Abstract: | |
| Keywords: | |